| ADR Ontology |
| ADR Term |
Hyperprolactinaemia |
| ADR ID |
BADD_A02141 |
| ADR Hierarchy |
|
| Description |
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8) [MeSH] |
| MedDRA Code |
10020737 |
| MeSH ID |
D006966; D006966; D006966
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Hyperprolactinaemia | Hyperprolactinaemia aggravated | Hyperprolactinemia | Hyperprolactinemia aggravated | Hyperprolactinemias | Prolactin, Inappropriate Secretion | Inappropriate Secretion Prolactin | Secretion Prolactin, Inappropriate | Inappropriate Prolactin Secretion Syndrome | Prolactin Hypersecretion Syndrome | Hypersecretion Syndrome, Prolactin | Syndrome, Prolactin Hypersecretion | Inappropriate Prolactin Secretion | Prolactin Secretion, Inappropriate | Secretion, Inappropriate Prolactin |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
